Abstract: The invention relates to novel ureas and urethanes of Formula I: ##STR1## which stimulate cytokine production and may be used to accelerate recovery from neutropenia accompanying radio- or chemotherapy, bone marrow transplantation, or infections. Compounds in the invention or pharmaceutical compositions employing these compounds may be useful in the treatment of cancer, AIDS, aplastic anemia, myelodysplastic syndrome, and infectious diseases, and in the enhancement of immune response.
Type:
Grant
Filed:
May 12, 1993
Date of Patent:
May 17, 1994
Assignee:
American Cyanamid Company
Inventors:
Semiramis Ayral-Kaloustian, Steven R. Schow, Mila T. Du, James J. Gibbons, Jr.
Abstract: The invention discloses a cylindrical optical radiating device for obtaining controlled light distribution in a cylindrical pattern from an optical fiber. The device is constructed of a solid cylindrical tip made from material containing an optical scattering material in which a tapered central lumen having a conical shape has been drilled, cast or bored. Light emerging from the end of the fiber is radiated out in a cylindrical pattern through the use of the tapered central lumen.
Abstract: Novel processes, intermediates and reagents for the preparation of 3-substituted furanose or furanoside compounds of Formula I: ##STR1## wherein M is hydrogen or alkyl (C.sub.1 -C.sub.3), A is halogen or A may be selected from a moiety of the formula: OR, SR, N.sub.3, SCR, OC--R or CN wherein R is hydrogen, branched or unbranched alkyl (C.sub.1 -C.sub.4) or phenyl which compounds have antiviral and other biological activity.